Remimazolam
目录号: A22200
Remimazolam,也被称为 CNS-7056,是一种苯二氮䓬类衍生物药物,由 PAION 公司与其日本授权商小野制药合作开发,作为短效咪唑苯二氮䓬类药物咪达唑仑的替代品,用于麻醉诱导和轻度侵入性程序的意识镇静。
Discription | Remimazolam, also known as CNS-7056, is a benzodiazepine derivative drug, developed by PAION, in collaboration with Japanese licensee Ono Pharmaceutical as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in induction of anaesthesia and conscious sedation for minor invasive procedures. |
---|
目录号 | A22200 |
---|---|
分子式 | C21H19BrN4O2 |
分子量 | 439.31 |
CAS号 | 308242-62-8 |
SMILES | O=C(OC)CC[C@H]1C2=NC=C(C)N2C3=CC=C(Br)C=C3C(C4=NC=CC=C4)=N1 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2